|
Class 2 Device Recall Wako TASWako i30 |
|
Date Initiated by Firm |
February 18, 2021 |
Create Date |
April 13, 2021 |
Recall Status1 |
Terminated 3 on February 24, 2022 |
Recall Number |
Z-1412-2021 |
Recall Event ID |
87507 |
510(K)Number |
K100464
|
Product Classification |
Test, alpha fetoprotein l3 subfraction (afp-l3%), for hepatocellular carcinoma risk assessment - Product Code NSF
|
Product |
¿TASWako Chip Cassette is part of the Wako ¿TASWako i30 kit |
Code Information |
Lot Number: EQ194 Exp. Date: 05/31/2022 |
Recalling Firm/ Manufacturer |
Fujifilm Medical Systems U.S.A., Inc. 81 Hartwell Ave Ste 300 Lexington MA 02421-3160
|
For Additional Information Contact |
SAME 617-861-5300
|
Manufacturer Reason for Recall |
Potentially defective Chip Cassette units, when used for DCP or AFP-L3% measurement, incorrect DCP and AFP-L3% values may result
|
FDA Determined Cause 2 |
Under Investigation by firm |
Action |
Fujifilm issued Consignee notifications via courier delivery and electronic mail on February 18, 2021. The letter states reason for recall, health risk and action to take: FUJIFILM is recommending that you immediately cease use of any Cavity #2 chips in Lot EQ194 and return the product to FUJIFILM.
Please complete and return the Field Action Verification Form attached on page 3 of this communication. Providing the response with the information requested is essential for ensuring appropriate action is taken:
Upon receipt of the Field Action Verification Form, FUJIFILM will provide replacement chip cassette boxes (each containing 5 x 20 chips) from a different lot.
Please contact our field action coordinator, Jeffrey Wan, via phone at 201-675-8947 or email at jeffrey.wan@fujifilm.com, if you have any further questions regarding this field action. |
Quantity in Commerce |
496 units |
Distribution |
CA, LA, MN, NC, UT, WI |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database |
510(K)s with Product Code = NSF and Original Applicant = WAKO CHEMICALS USA, INC.
|
|
|
|